Page 2 - Vor Biopharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Vor biopharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Vor Biopharma Today - Breaking & Trending Today

Vor Biopharma (NYSE:VOR) Receives Outperform Rating from Wedbush

Vor Biopharma (NYSE:VOR) Receives Outperform Rating from Wedbush
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Stifel Nicolaus , Securities Exchange Commission , Vor Biopharma Inc , Sg Americas Securities , Vor Biopharma , Get Free Report , Biopharma Stock Down , Free Report , Biopharma Inc , Vor Biopharma Daily ,

Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United Kingdom , Sarah Spencer , Vor Biopharma Inc , Compensation Committee Of The Board Directors , Compensation Committee , Vor Bio , Nasdaq Listing Rule , Vor Biopharma , Inducement Plan ,

Vor Biopharma's (VOR) "Outperform" Rating Reiterated at Wedbush

Wedbush reissued their outperform rating on shares of Vor Biopharma (NYSE:VOR – Free Report) in a research report released on Tuesday, Benzinga reports. Wedbush currently has a $11.00 price target on the stock. A number of other equities research analysts have also recently issued reports on the stock. Stifel Nicolaus reduced their target price on […] ....

Stifel Nicolaus , Vor Biopharma Inc , Exchange Traded Concepts , Securities Exchange Commission , Vor Biopharma , Free Report , Biopharma Stock Down , Get Free Report , Traded Concepts , Biopharma Inc , Vor Biopharma Daily ,

Wedbush Reiterates "Outperform" Rating for Vor Biopharma (NYSE:VOR)

Wedbush Reiterates "Outperform" Rating for Vor Biopharma (NYSE:VOR)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Stifel Nicolaus , Vor Biopharma Company Profile , Exchange Traded Concepts , Exchange Commission , Vor Biopharma Inc , Vor Biopharma , Free Report , Biopharma Trading Down , Get Free Report , Traded Concepts , Biopharma Inc , Vor Biopharma Daily ,

PureTech Announces Annual Results for Year Ended December 31, 2023

Significant operational and clinical progress in 2023 and early 2024 with maturation of Internal Programs,1 launch of two new Founded Entities,2 including a $100 million Series A financing for. ....

United Kingdom , United States , City Of , Bharatt Chowrira , La Monte Carlo , Daphne Zohar , Castro Pereira , Pirfenidone Esbriet , Eric Elenko , Monte Carlo , Bristol Myers Squibb , Karuna Kar , Raju Kucherlapati , Eli Lilly , Stevenm Paul , Robert Langer , Sven Dethlefs , Julie Krop , Bristol Meyers Squibb , Charles Sherwood , John Lamattina , Teva Pharmaceuticals , Us Department Of Defense , Foreign Currency Exchange Risk , Censof Holdings , European Medicines Agency ,